Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,610 | -58,068 | -27,678 | -3,524 | -27,841 |
| Depreciation Amortization | 2,138 | 8,769 | 6,600 | 4,398 | 2,197 |
| Accounts receivable | 3,200 | 4,957 | 7,713 | -2,683 | 9,468 |
| Accounts payable and accrued liabilities | -3,273 | -298 | -4,482 | -3,047 | -4,978 |
| Other Working Capital | -7,039 | 24,523 | 23,319 | 11,554 | 2,005 |
| Other Operating Activity | 8,449 | 27,225 | 20,181 | 20,722 | 1,891 |
| Operating Cash Flow | $-27,135 | $7,108 | $25,653 | $27,420 | $-17,258 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 7,874 | N/A | N/A | N/A |
| PPE Investments | -631 | -1,252 | -1,106 | -1,019 | -898 |
| Purchase Of Investment | -30 | N/A | -72 | -46 | -19 |
| Sale Of Investment | 24,069 | N/A | 16,915 | 8,217 | 5,976 |
| Investing Cash Flow | $23,408 | $6,622 | $15,737 | $7,152 | $5,059 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -101 | -403 | -302 | -201 | -101 |
| Common Stock Issued | 3,099 | 9,881 | 6,137 | 4,496 | 1,213 |
| Other Financing Activity | -2,424 | -2,740 | -2,242 | -1,791 | -1,261 |
| Financing Cash Flow | $574 | $6,738 | $3,593 | $2,504 | $-149 |
| Exchange Rate Effect | -31 | -10 | -24 | 11 | -17 |
| Beginning Cash Position | 173,782 | 153,324 | 153,324 | 153,324 | 153,324 |
| End Cash Position | 170,598 | 173,782 | 198,283 | 190,411 | 140,959 |
| Net Cash Flow | $-3,184 | $20,458 | $44,959 | $37,087 | $-12,365 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,135 | 7,108 | 25,653 | 27,420 | -17,258 |
| Capital Expenditure | -636 | -1,252 | -1,106 | -1,019 | -898 |
| Free Cash Flow | -27,771 | 5,856 | 24,547 | 26,401 | -18,156 |